中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
10期
22-23,24
,共3页
李兴禹%席多宏%李青松%何立春
李興禹%席多宏%李青鬆%何立春
리흥우%석다굉%리청송%하립춘
胃上部癌%全胃切除术%近端胃切除术%疗效对比%临床意义
胃上部癌%全胃切除術%近耑胃切除術%療效對比%臨床意義
위상부암%전위절제술%근단위절제술%료효대비%림상의의
Upper stomach cancer%Total gastrectomy%Proximal gastrectomy%Clinical effect comparison%Clinical significance
目的:研究讨论胃上部癌行全胃切除与近端胃切除的临床疗效对比与意义。方法选取本院外科胃上部癌患者100例,其中50例采用全胃切除术治疗,50例采用近端胃切除术治疗,分别对两组患者治疗后并发症发生情况、手术后生存率以及术后恢复情况进行评估。结果两组患者治疗后并发症发生率比较显示行全胃切除术患者并发症发生率显著低于近端胃切除术患者(P<0.05);治疗后癌灶大小与患者生存率比较显示癌灶>3 cm与<3 cm治疗后1年生存率无较大差异(P>0.05);治疗后3~5年全胃切除术生存率显著较高(P<0.05)。恢复情况比较显示治疗后近端胃切除术患者各项恢复指标优于全胃切除术组患者(P<0.05)。结论胃上部癌要根据肿瘤的大小,分期,采取合理的手术方式,全胃切除术可降低术后相关并发症,改善生活质量,提高生存率,临床疗效更为确切。
目的:研究討論胃上部癌行全胃切除與近耑胃切除的臨床療效對比與意義。方法選取本院外科胃上部癌患者100例,其中50例採用全胃切除術治療,50例採用近耑胃切除術治療,分彆對兩組患者治療後併髮癥髮生情況、手術後生存率以及術後恢複情況進行評估。結果兩組患者治療後併髮癥髮生率比較顯示行全胃切除術患者併髮癥髮生率顯著低于近耑胃切除術患者(P<0.05);治療後癌竈大小與患者生存率比較顯示癌竈>3 cm與<3 cm治療後1年生存率無較大差異(P>0.05);治療後3~5年全胃切除術生存率顯著較高(P<0.05)。恢複情況比較顯示治療後近耑胃切除術患者各項恢複指標優于全胃切除術組患者(P<0.05)。結論胃上部癌要根據腫瘤的大小,分期,採取閤理的手術方式,全胃切除術可降低術後相關併髮癥,改善生活質量,提高生存率,臨床療效更為確切。
목적:연구토론위상부암행전위절제여근단위절제적림상료효대비여의의。방법선취본원외과위상부암환자100례,기중50례채용전위절제술치료,50례채용근단위절제술치료,분별대량조환자치료후병발증발생정황、수술후생존솔이급술후회복정황진행평고。결과량조환자치료후병발증발생솔비교현시행전위절제술환자병발증발생솔현저저우근단위절제술환자(P<0.05);치료후암조대소여환자생존솔비교현시암조>3 cm여<3 cm치료후1년생존솔무교대차이(P>0.05);치료후3~5년전위절제술생존솔현저교고(P<0.05)。회복정황비교현시치료후근단위절제술환자각항회복지표우우전위절제술조환자(P<0.05)。결론위상부암요근거종류적대소,분기,채취합리적수술방식,전위절제술가강저술후상관병발증,개선생활질량,제고생존솔,림상료효경위학절。
Objective To study and discuss the comparison and significance between clinical effects of total gastrectomy and proximal gastrectomy for treatment of upper stomach cancer. Methods 100 patients with upper stomach cancer were chosen and divided randomly into A group and B group. 50 patients of A group were given total gastrectomy while B group was given proximal gastrectomy. Complications, survival rates and recovery conditions after operations of the 2 groups were evaluated. Results Occurrence rate of complications of B group was obviously lower than A group (P<0.05). No significant differences existed between survival rates 1 year after treatments of the 2 groups (P>0.05);survival rates 3 and 5 years after treatments of A group were obviously higher than B group (P<0.05). Recovery indicators after treatment of B group were all superior to A group (P<0.05). Conclusion Total gastrectomy and proximal gastrectomy both have significant clinical effects for treatment of upper stomach cancer. Total gastrectomy can remove lesions completely and avoid recurrence of lesions. Proximal gastrectomy has few postoperative complications, high safety and high survival rate. Patient’s condition should be evaluated detailedly before chose and implement of surgical method.